Perceptions and predictors of intention to receive the COVID-19 vaccine

被引:50
作者
Coe, Antoinette B. [1 ]
Elliott, Marissa H. [1 ]
Gatewood, Sharon B. S. [2 ]
Goode, Jean-Venable R. [2 ]
Moczygemba, Leticia R. [3 ]
机构
[1] Univ Michigan, Dept Clin Pharm, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
[2] Virginia Commonwealth Univ, Sch Pharm, 410 N 12th St, Richmond, VA 23298 USA
[3] Univ Texas Austin, Coll Pharm, 2408 Univ Ave, Austin, TX 78712 USA
关键词
COVID-19; vaccine; Pandemic; Health belief model; ACCEPTANCE;
D O I
10.1016/j.sapharm.2021.04.023
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The control of the Coronavirus Disease 2019 (COVID-19) pandemic may be dependent on widespread receipt of an effective vaccine. It is important to understand patient health-related behaviors and perceptions to guide public health vaccination strategies. Objectives: To examine perceptions of COVID-19 and vaccination beliefs, and identify predictors of intention to receive the COVID-19 vaccine in the US. Methods: A cross-sectional, web-based survey guided by the Health Belief Model was conducted using a web based Qualtrics survey panel of US adults. The main outcome was the intention to receive the COVID-19 vaccine if offered. Additional measures included: demographics, perceptions of COVID-19 severity, risk and susceptibility, views of a potential COVID-19 vaccine, virus and vaccine information sources, vaccine beliefs and behaviors, and seasonal flu vaccine history. Results: A total of 1047 complete responses were included. Females had lower odds of intending to receive the COVID-19 vaccine than males (AOR = 0.54, 95% CI: 0.36-0.80). Those with a two-year degree/some college had lower odds of intending to receive the COVID-19 vaccine compared to those with a high school degree/GED (AOR = 0.59, 95% CI: 0.36-0.97). Respondents who perceived the severity of the virus to be higher, perceived a greater COVID-19 vaccine benefit, and perceived greater general vaccine benefits had higher odds of intending to receive a COVID-19 vaccine (AOR = 1.44, 95% CI: 1.09-1.91; AOR = 2.82, 95% CI: 2.24-3.56; AOR = 1.77, 95% CI 1.41-2.21, respectively). Conclusions: In this study, intention to receive the COVID-19 vaccine varied across demographics, perceived virus severity, COVID-19 vaccine and general vaccine beliefs. Successful implementation of a COVID-19 immunization strategy by healthcare providers and public health officials will need to incorporate diverse COVID-19 vaccination education strategies tailored to patients' health beliefs.
引用
收藏
页码:2593 / 2599
页数:7
相关论文
共 20 条
[1]  
[Anonymous], 2017, FireEye
[2]  
Centers for Disease Control and Prevention, COR DIS 2019 COVID 1
[3]  
Champion Tiro., 2015, HLTH BEHAV THEORY RE, V5, P75, DOI DOI 10.1093/JNCI/DJV120
[4]   Integrating health behavior theories to predict American's intention to receive a COVID-19 vaccine [J].
Chu, Haoran ;
Liu, Sixiao .
PATIENT EDUCATION AND COUNSELING, 2021, 104 (08) :1878-1886
[5]  
Coe Antoinette B, 2012, Innov Pharm, V3, P1
[6]   Willingness to get the COVID-19 vaccine with and without emergency use authorization [J].
Guidry, Jeanine P. D. ;
Laestadius, Linnea I. ;
Vraga, Emily K. ;
Miller, Carrie A. ;
Perrin, Paul B. ;
Burton, Candace W. ;
Ryan, Mark ;
Fuemmeler, Bernard F. ;
Carlyle, Kellie E. .
AMERICAN JOURNAL OF INFECTION CONTROL, 2021, 49 (02) :137-142
[7]  
Johns Hopkins University Coronavirus Resource Center, WORLD MAP US MAP
[8]   Factors Associated With US Adults' Likelihood of Accepting COVID-19 Vaccination [J].
Kreps, Sarah ;
Prasad, Sandip ;
Brownstein, John S. ;
Hswen, Yulin ;
Garibaldi, Brian T. ;
Zhang, Baobao ;
Kriner, Douglas L. .
JAMA NETWORK OPEN, 2020, 3 (10)
[9]   Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007-2012 [J].
Larson, Heidi J. ;
Jarrett, Caitlin ;
Eckersberger, Elisabeth ;
Smith, David M. D. ;
Paterson, Pauline .
VACCINE, 2014, 32 (19) :2150-2159
[10]   Addressing barriers to vaccine acceptance: an overview [J].
MacDonald, Noni E. ;
Butler, Robb ;
Dube, Eve .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (01) :218-224